Table 1.
Total (n=11,649) |
No Chronic Condition (n=9,787) |
Chronic Condition (n=1,862) |
P | ||
---|---|---|---|---|---|
Age (y)† | 0.065 | ||||
21–29 | 2,637 (22.6) | 2,246 (23.0) | 391 (21.0) | ||
30–42 | 9,012 (77.4) | 7,541 (77.0) | 1,471 (79.0) | ||
Race† | |||||
White | 8,435 (72.4) | 7,087 (72.4) | 1,348 (72.4) | 0.380 | |
Black | 1,408 (12.1) | 1,179 (12.1) | 229 (12.3) | ||
Other (non-Hispanic) | 359 (3.1) | 313 (3.2) | 46 (2.5) | ||
Missing | 1,447 (12.4) | 1,208 (12.3) | 239 (12.8) | ||
Community-level socioeconomic status† | 0.038 | ||||
< 200% FPL | 1,636 (14.1) | 1,346 (13.8) | 290 (15.7) | ||
≥ 200% FPL | 9,952 (85.9) | 8,390 (86.2) | 1,562 (84.3) | ||
Missing | 61 (0.5) | 51 (0.5) | 10 (0.5) | ||
No. of chronic conditions | -- | ||||
1 | -- | -- | 1,396 (75.0) | ||
≥2 | -- | -- | 466 (25.0) | ||
Outpatient visits ‡ | <0.001 | ||||
Total in 3 years | 6.7 ± 0.1 | 4.9 ± 0.1 | 16.0 ± 0.4 | ||
Average per year | 2.2 ± 0.0 | 1.6 ± 0.0 | 5.3 ± 0.1 | ||
Had a health maintenance visit† | 4,026 (34.6) | 2,941 (30.1) | 1,085 (58.3) | <0.001 | |
No. years with cervical cancer screening, by age (y)† | |||||
21–29 | <0.001 | ||||
0 | 1,425 (56.4) | 1,256 (55.9) | 169 (43.2) | ||
1 | 842 (31.9) | 725 (32.3) | 117 (29.9) | ||
≥2 | 370 (14.0) | 265 (11.8) | 105 (26.9) | ||
30–42 | <0.001 | ||||
0 | 4,844 (53.8) | 4,214 (55.9) | 630 (42.8) | ||
1 | 2,745 (30.5) | 2,289 (30.4) | 456 (31.0) | ||
≥2 | 1,423 (15.8) | 1,038 (13.8) | 385 (26.2) | ||
Received contraception in 3 years, by age (y)† | |||||
Overall | 4,641 (39.8) | 4,018 (41.1) | 623 (33.5) | <0.001 | |
21–29 | 1,708 (64.8) | 1,489 (66.3) | 219 (56.0) | ||
30–45 | 2,933 (32.6) | 2,529 (33.5) | 404 (27.5) | ||
Proportion of months in 3 years with contraception supply among contraceptive users, by age (y) ‡ | 0.025 | ||||
Overall | 0.54 ± 0.0 | 0.55 ± 0.0 | 0.51 ± 0.0 | ||
21–29 | 0.54 ± 0.0 | 0.54 ± 0.0 | 0.52 ± 0.0 | ||
30–42 | 0.55 ± 0.0 | 0.55 ± 0.0 | 0.51 ± 0.0 |
FPL, federal poverty level.
Data are n(%). Proportions with chronic conditions across covariate groups were compared using the Chi-square test.
Data are mean ± standard error of the mean. Mean proportions of contraceptive supply across age groups were compared using the Wilcoxon Rank Sum test.